Tag: <span>Diagnosed AML</span>

Home / Diagnosed AML
Post

FDA Approves Quizartinib for Newly Diagnosed AML

M. Alexander Otto, PA, MMS July 20, 2023 The US Food and Drug Administration today approved quizartinib (Vanflyta) for adults with acute myeloid leukemia (AML) that carries the FLT3-ITD genetic mutation. The FDA also approved the LeukoStrat CDx FLT3 Mutation Assay to determine whether patients have this mutation. The agency granted quizartinib a first-line indication for use in combination with standard chemotherapy — cytarabine and...